Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for detecting content of heparin in plasma

A technology of heparin and detection label, applied in the field of detection of heparin content in plasma, can solve the problem of insufficient detection methods of heparin, and achieve the effects of good application value, good sensitivity and good specificity

Active Publication Date: 2021-11-02
贵州安康医学检验中心有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] But at present, there are not enough detection methods for heparin, and it is imminent to develop different detection ideas

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for detecting content of heparin in plasma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Embodiment 1 heparin preparation

[0029]Add 100 g of isolated lung tissue to distilled water at a ratio of 1:10 (g:mL), crush it sufficiently in a tissue grinder until it becomes minced meat, and transfer it to a 1000 mL beaker for later use. Use 2mol / L NaOH solution to adjust the pH of the minced meat in the cup to 8.5, add 2% protease for 3 hours, add 5% NaCl of the sample amount, stir for 30 seconds every 10 minutes at 60°C, continue this operation for 2 hours, and immediately raise the temperature to 100 °C, let stand for 10 minutes to precipitate protein, filter through 100 mesh sieve, and collect the filtrate. The filtrate is cooled to 50°C, adjust the pH to 8.5 with 2mol / L NaOH, add 8% Dow AMBERLITETM FPA98CL food-grade special polymer (resin) resin (resin is rinsed to neutral with distilled water), in a constant temperature magnetic stirrer at 50°C , continuously adsorbed for 8 hours, filtered through a 100-mesh sieve, and collected the resin for later use. P...

Embodiment 2

[0030] Example 2 Preparation of Heparin-specific Monoclonal Antibody

[0031] Dissolve 1 mg of antigen absorbed by heparin prepared in Example 1 into 1 ml of physiological saline, and mix thoroughly to prepare an antigen solution with a concentration of 1 mg / ml.

[0032] The immunogen emulsified repeatedly was used to immunize 6-week-old female Balb / c mice for 6 times in total. The specific scheme was as follows: for the first immunization, the immunogen was added with complete Freund’s adjuvant, and the volume ratio of the two was 1:1. Mixed, multi-point injection of mouse foot pads and abdomen subcutaneously, 60ug / mouse, next immunization after 2 weeks; for the 2nd to 5th immunization, after fully emulsifying the immunogen and Freund’s incomplete adjuvant, mouse foot pads , Subcutaneous multi-point injection, 30ug / mouse, each time at an interval of 2 weeks; take serum, measure the titer, select the mouse with the best titer and inject 100ul, 50ug of immunogen intraperitoneal...

Embodiment 31B4

[0043] Example 3 Identification of 1B4 antibody affinity

[0044] Using the AMC sensor, the purified 1B4 antibody was diluted to 10ug / ml with PBST, and the heparin was serially diluted with PBST: 444.4nmol / ml, 222.2nmol / ml, 111.1nmol / ml, 55.6nmol / ml, 27.8nmol / ml, 0nmol / ml; operation process: equilibrate in PBST for 60s, immobilize antibody in antibody solution for 300s, incubate in PBST for 180s, bind in antigen solution for 420s, dissociate in buffer 2 for 1200s, use 10mM pH 1.69GLY solution for sensor regeneration, output data , (KD represents the equilibrium dissociation constant or affinity), the results show that the Kd value of the 1B4 antibody is 2.37E-09M, which has good binding properties.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention relates to a method for detecting the content of heparin in plasma. The monoclonal antibody aiming at the heparin is prepared and obtained by adopting a hybridoma method, and the antibody has better specificity and sensitivity, can be used for measuring the content of the heparin in a blood sample, and has better application value.

Description

technical field [0001] The invention relates to the field of biological detection, in particular to a detection method for heparin content in blood plasma. Background technique [0002] Heparin was first discovered in the liver and got its name. It is a mucopolysaccharide sulfate composed of glucosamine, L-iduroside, N-acetylglucosamine and D-glucuronic acid alternately. It has an average molecular weight of 15KDa and is strongly acidic. It also exists in lungs, blood vessel walls, intestinal mucosa and other tissues, and is a natural anticoagulant substance in animals. Naturally present in mast cells, it is now mainly extracted from bovine lung or pig small intestinal mucosa. As an anticoagulant, it is a polymer composed of two polysaccharides connected alternately, and has anticoagulant effects both in vivo and in vitro. Clinically, it is mainly used for thromboembolic diseases, myocardial infarction, cardiovascular surgery, cardiac catheterization, extracorporeal circul...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/18G01N33/577G01N33/574G01N33/53
CPCC07K16/18G01N33/577G01N33/57407G01N33/57488G01N33/5308C07K2317/56C07K2317/92G01N2400/40
Inventor 马红妙张然
Owner 贵州安康医学检验中心有限公司